BenevolentAI Investor Presentation Deck

Huge burden on society demands a new approach 96% overall failure rate in drug development $2.6bn in average R&D and to market cost per drug 10 to m years 30-50% efficacy for leading drugs Gaining a clear understanding of the underlying molecular mechanisms of disease based on the totality of available biomedical data is a vital step in the development of successful and efficacious treatments Benevolent 6

View entire presentation